Ferring Inc. announced Health Canada has issued a Notice of Compliance, approving REBYOTA® (fecal microbiota, live), a novel first-in-class microbiome-restoration therapy indicated for the prevention ...
Study authors say the results in immunocompromised patients are consistent with those from previous clinical studies of the ...
How does the cost of Vowst compare with the cost of Rebyota? The cost of Vowst compared with the cost of Rebyota depends on several factors. These include your treatment plan, insurance coverage ...
Avian flu was found most often in two communities with important wild bird habitats, which the authors say points to wild ...
The overdose crisis is one of the most serious public health crises our country has ever faced. It is driven by a dangerous illegal drug supply that is unpredictable and increasingly toxic. Too many ...
diff Infection Across 5 studies in the clinical development program, 7 encompassing safety data of 978 trial participants through 6 months, REBYOTA ® was well tolerated with primarily mild to moderate ...
months, REBYOTA ® was well tolerated with primarily mild to moderate treatment-emergent adverse events (TEAEs) and most were related to preexisting conditions. Through six months, incidence of ...
Despite near-significant Phase 2 data, Recursion's lead drug REC-994 for CCM remains unconvincing as a validation of their AI platform, being a repurposed compound. Pipeline expansion in oncology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results